Crossref
Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?
JAMA · 04.08.2026 · 336 (5) · 360
DOI: 10.1001/jama.2026.13149 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 04.08.2026. Verfasst von Kate Schweitzer. Beteiligte Einrichtung: Associate Managing Editor, Medical News, JAMA.
Abstract (Originalsprache)
This Medical News article discusses a request from the US Department of Health and Human Services to update testosterone therapy product labels following evolving scientific evidence of their safety.
Autor:innen und Institutionen
- Associate Managing Editor, Medical News, JAMA.
Zitieren
APA
Schweitzer, K. (2026). Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?. JAMA, 336(5), 360. https://doi.org/10.1001/jama.2026.13149
Vancouver
Schweitzer K. Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?. JAMA. 2026;336(5):360. doi:10.1001/jama.2026.13149
BibTeX
@article{Schweitzer2026,
author = {Schweitzer, Kate},
title = {Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?},
journal = {JAMA},
year = {2026},
volume = {336},
number = {5},
pages = {360},
doi = {10.1001/jama.2026.13149}
}
EUVIMED